To require a review of women and lung cancer, and for other purposes.
Sponsors
Legislative Progress
Passed HouseMr. Boyle of Pennsylvania (for himself, Mr. Fitzpatrick, Ms. Blunt …
Passed House (inferred from eh version)
Summary
What This Bill Does
Requires review of women and lung cancer, highlighting that lung cancer is the leading cause of cancer death among women. Notes higher incidence in women never-smokers and calls for research and preventive services review.
Who Benefits and How
Women at risk for lung cancer benefit from increased research focus. Healthcare providers gain better understanding of gender differences in lung cancer. Non-smoking women benefit from attention to their elevated risk.
Who Bears the Burden and How
Federal research agencies must conduct reviews. No significant new costs imposed.
Key Provisions
- 164 women die of lung cancer daily in U.S.
- Higher incidence in women never-smokers vs men never-smokers
- Adenocarcinoma (most common in non-smokers) more common in women
- Radon exposure accounts for 21,000 lung cancer deaths annually
Evidence Chain:
This summary is derived from the structured analysis below. See "Detailed Analysis" for per-title beneficiaries/burden bearers with clause-level evidence links.
Primary Purpose
Requires review of women and lung cancer research and preventive services
Policy Domains
Legislative Strategy
"Focus research attention on gender disparities in lung cancer"
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology